Global Modular Manufacturing Facilities Market in Pharmaceutical and Biotechnology 2023: Industry Trends and Forecasts - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Modular Manufacturing Facilities Market in Pharmaceutical and Biotechnology: Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndMarkets.com's offering.

This report features an extensive study of the current market landscape and future opportunity, offering an informed opinion on the likely adoption of modular facilities in the pharmaceutical and biotechnology industries, over the next 12 years. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

In the past few years, modular facilities or prefabricated buildings have emerged as a promising alternative to the conventionally built pharma / biotech manufacturing facilities. Modular manufacturing facility construction involves building of structures using prefabricated modular units, off-site, under controlled factory setting; these modular manufacturing units are later assembled on site. It is interesting to note that off-site construction can eliminate 60%-90% of the weather-related project concerns.

Further, modular facilities can be built 40% faster as compared to a conventional construction, which could take up to three years. Therefore, considering the various advantages offered by this approach, several pharmaceutical players are now shifting their focus from conventional plants to modular manufacturing facilities. Specifically, modular facility providers are catering to the needs of various players engaged in the development of therapeutics, including cell and gene therapy, biosimilars and vaccines.

To provide more context, modular biomanufacturing includes division of individual production processes, such as fermentation, purification and formulation, into separate modules that can be easily assembled and disassembled, allowing for flexibility and scalability.

In addition, modular manufacturing allows the use of smaller-scale production units, which can be more flexible and responsive to dynamic market demands. Moreover, temporary modular buildings can be relocated after installation, based on needs of the end-user.

However, mass production, complex decision-making, construction approvals and early financing can hinder the adoption of modular constructs. If healthcare stakeholders are able to overcome these challenges, modular construction can serve as a lucrative approach that provides greater flexibility and enables faster time-to-market for new products.

This report features an extensive study of the current market landscape and future opportunity, offering an informed opinion on the likely adoption of modular facilities in the pharmaceutical and biotechnology industries, over the next 12 years. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

Company Profiles

• Cytiva
• G-CON Manufacturing
• Germfree
• IPM Technologies
• KeyPlants
• ModuleCo Pharma
• NNE
• Pharmadule

Key Advantages Offered by Modular Facilities

Modular manufacturing facilities have emerged as a promising alternative to conventional facilities owing to the multiple benefits that they offer. For instance, modular facilities can help in achieving 25%-30% reduction in the overall cost of construction, minimal plant site interruption, 50%-60% faster construction timelines, as well as ensure portability, safe working conditions and sustainability.

In addition, better quality of products can be achieved by modular construction approaches owing to the fact that modules are built in a controlled factory setting.

In addition, these modules are inspected more thoroughly and frequently before they are shipped to the construction site meeting desired quality standards. Moreover, modular construction allows more flexibility in terms of design, as a higher number of materials and finishes can be used, as compared to conventional facilities.

Current Market Landscape of Modular Manufacturing Facilities

The modular facilities market landscape features an extensive list of over 50 large, mid-sized, small and very small players. It is worth highlighting that more than 250 players are engaged in offering modular cleanrooms, along with various cleanroom accessories and customization options, in order to make them suitable for application in the life sciences industry.

It is expected that modular facilities will become more streamlined and standardized in the future, serving as an efficient cost saving solution.

Key Drivers in the Modular Facilities Market

Over the past few years, several factors have contributed to reform the facility construction paradigm within the pharmaceutical and biotechnology industries.

The increasing preference and demand for personalized therapies and novel therapeutic interventions intended for the treatment of various ailments has compelled pharmaceutical companies to look beyond the traditional manufacturing and expansion practices. Lack of adequate manufacturing infrastructure, increased cost of construction and delay in project deliveries has collectively contributed to the emergence of off-site construction models.

Overall Size of Modular Facilities Market

Driven by the rising interest of stakeholders towards improvement of manufacturing and production efficiency, the anticipated lucrative opportunities and growth associated with adoption of modular manufacturing facilities, this market is expected to witness noteworthy growth in the foreseen future. Specifically, in terms of type of product, the market is anticipated to be driven by manufacturing units for cell and gene therapies, as well as vaccines and biosimilars.

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS

5. MARKET LANDSCAPE: MODULAR CLEANROOM PROVIDERS

6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS

7. COMPANY PROFILES

8. PARTNERSHIPS AND COLLABORATIONS

9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY

10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY

11. COST-TIME OPTIMIZATION FRAMEWORK

12. MARKET FORECAST

13. PREVALENT AND EMERGING INDUSTRY TRENDS

14. FUTURE GROWTH OPPORTUNITIES

15. CONCLUSION

16. EXECUTIVE INSIGHTS

17. APPENDIX I: TABULATED DATA

18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION

For more information about this report visit https://www.researchandmarkets.com/r/cytz3m

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900